Magdalena Schlotter

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

BCAT1 redox function maintains mitotic fidelity.

BCAT1 redox function maintains mitotic fidelity.

Journal: Cell reports
Published: March 02, 2023

BCAT1 redox function maintains mitotic fidelity.

BCAT1 redox function maintains mitotic fidelity.

Journal: Cell reports
Published: March 07, 2021

Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype.

Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype.

Journal: Nature communications
Published: April 20, 2020

GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile.

GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile.

Journal: Cell stem cell
Published: March 01, 2018

Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype.

Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype.

Journal: EMBO reports
Published: March 01, 2017

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.

Journal: Oncogene
Published: May 12, 2016

Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.

Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.

Journal: Oncotarget
Published: February 02, 2016

Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.

Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.

Journal: Cancer research
Published: February 04, 2015

BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.

BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.

Journal: Nature medicine
Published: February 15, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026